August 01, 2014 1:28 PM ET

Health Care Technology

Company Overview of Epocrates, Inc.

Company Overview

Epocrates, Inc. develops medical application for clinical content, practice tools, and health industry engagement at a point of care. It offers Epocrates medical application that provides clinical tools to integrate into daily workflow of physicians; and online and mobile solutions to access and provide clinical content for healthcare professionals and students, including premium drug reference, complete disease and treatment guide, built-in clinical tables and guidelines, dosing and medical calculators, and access to institution's formulary. The company also provides Epocrates CME that provides access to CME/CE activities on iPhone and Android mobile devices; and product licensing services....

1100 Park Place

Suite 300

San Mateo, CA 94403

United States

Founded in 1998

320 Employees

Phone:

650-227-1700

Fax:

650-227-2770

Key Executives for Epocrates, Inc.

Chief Executive Officer
Age: 50
President
Age: 52
Senior Vice President of Commercial Operations
Age: 43
Executive Director of Medical Information
Vice President
Age: 44
Compensation as of Fiscal Year 2014.

Epocrates, Inc. Key Developments

athenahealth, Inc. and Epocrates Announce Two Point-Of-Care Innovations to Improve Providers' Access to Information in Moments of Care

athenahealth, Inc. and Epocrates announced two point-of-care innovations to improve providers' access to information in moments of care. Health care providers can leverage the power of Epocrates in the following ways: Directly within the athenaClinicals(R) EHR -- As of February 22, key drug monograph content from Epocrates' valued and trusted drug reference, Epocrates Rx(R), will be available as part of athenaClinicals, the most usable ambulatory electronic medical record (EMR) system, as rated by health care providers in the 2013 KLAS report on Ambulatory EMR Usability. As part of a new workflow, providers who use athenaClinicals will gain streamlined access to valuable information on dosing, contraindications, adverse reactions, and other key safety information for thousands of brand and generic drugs without having to leave their EHR interface. Additional sections of Epocrates' drug monographs will be introduced into athenaClinicals over time. Through the Enhanced Drug Interaction Features in the Epocrates App -- Epocrates has upgraded its InteractionCheck(R), the most valued Epocrates feature affecting prescribing changes, as well as its drug monographs (complete with a new Drug Interaction Overview section). Health care providers now have access to advanced, detailed profiles of a drug's interaction potential and risks to better determine why potentially harmful drug interactions occur, to more easily identify individual ingredients responsible, and to help make necessary adjustments or substitutions. These features are exclusively found in the Epocrates mobile app or on Epocrates(R) Online.

Epocrates, Inc. Announces Executive Changes; Announces Amendments to Articles of Incorporation

On March 12, 2013, pursuant to the terms of the Agreement and Plan of Merger dated as of January 7, 2013, among Epocrates, Inc., athenahealth, Inc., and Echo Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of athenahealth, Merger Sub was merged with and into Epocrates, with Epocrates being the surviving corporation. Upon completion of the Merger, Epocrates became a wholly-owned subsidiary of athenahealth. The Merger Agreement and the transactions contemplated thereby, including the Merger, were previously approved by Epocrates' board of directors and by its stockholders at a special meeting of the stockholders held on March 11, 2013. As of the effective time of the Merger on March 12, 2013, in connection with the Merger, the following directors voluntarily resigned from Epocrates' board of directors: Peter C. Brandt, Philippe O. Chambon, M.D., Ph.D., Gary G. Greenfield, Thomas L. Harrison, Andrew Hurd, Patrick S. Jones, Erick N. Tseng, and Mark A. Wan. Following the Merger and pursuant to the terms of the Merger Agreement, at the effective time of the Merger on March 12, 2013, the size of the Board of Directors of Epocrates was reduced to one member and Daniel Orenstein was appointed as the sole member of the Board of Directors of Epocrates. Following the Merger and pursuant to the terms of the Merger Agreement, at the effective time of the Merger on March 12, 2013, the officers of Merger Sub immediately prior to the effective time of the Merger became the officers of Epocrates, with Jonathan Bush appointed as President of Epocrates and Daniel Orenstein appointed as Vice President, Secretary, and Treasurer of Epocrates. Following the Merger and pursuant to the terms of the Merger Agreement, at the effective time of the Merger on March 12, 2013, the officers of Merger Sub immediately prior to the effective time of the Merger became the officers of Epocrates, with Jonathan Bush appointed as President of Epocrates and Daniel Orenstein appointed as Vice President, Secretary, and Treasurer of Epocrates. On March 12, 2013, in connection with the Merger, the Bylaws of athenahealth as in effect immediately prior to the effective time of the Merger became the Bylaws of Epocrates.

Epocrates, Inc.(NasdaqGS:EPOC) dropped from NASDAQ Composite Index

Epocrates, Inc. will be removed from NASDAQ Composite Index

Similar Private Companies By Industry

Company Name Region
FMRS, Inc. United States
IPNT, Inc. United States
SecureTrack, Inc. United States
NCC Inc. United States
Patientfile, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Epocrates, Inc., please visit www.epocrates.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.